Abstracts tagged "Capillaroscopy"

Abstract Number: 686 • 2017 ACR/ARHP Annual Meeting
Endothelial Dysfunction in Systemic Lupus Erythematosus Patients without Cardiovascular events and Risk Factors: Correlation with Microvascular Alterations and angiogenic t Cells
Ilaria Cavazzana¹, Mara Taraborelli², Silvia Piantoni³, Ivano Bonadei⁴, Edoardo Sciatti⁵, Micaela Fredi⁶, Marco Metra⁴, Angela Tincani⁷, Franco Franceschini¹ and Enrico Vizzardi⁴, ¹Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, ²Internal Medicine; Ospedale Mellini, Chiari (Brescia), Italy, ³Rheumatology and Clinical Immunology Unit, Spedali Civili, University of Brescia, Brescia, Italy, ⁴Cardiology Unit, Spedali Civili, University of Brescia, Brescia, Italy, ⁵Cardiology Unit, Spedali Civili, University of Brescia, Brsecia, Italy, ⁶Department of Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, ⁷Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy
Background/Purpose: early identification of subclinical cardiovascular disease (CVD) in systemic lupus erythematosus (SLE) patients is mandatory to reduce morbidity and mortality. Endothelial dysfunction (ED) is…
Abstract Number: 1172 • 2017 ACR/ARHP Annual Meeting
Utility of Interstitial Pneumonia with Autoimmune Features (IPAF) Proposed Criteria in the Classification of Patients with CTD-Associated Interstitial Lung Disease in a Single Centre
Fredeswinda I. Romero-Bueno¹, Ana Sofía Pozo², Maria Jesus Rodriguez-Nieto³, Maria José Martinez-Becerra⁴, Gabriel Herrero-Beaumont⁵ and Olga Sanchez-Pernaute¹, ¹Section for Autoimmune Diseases, Rheumatology, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ²Faculty of Medicine, Autonoma University of Madrid, Madrid, Spain, ³Pulmonary Medicine, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ⁴Immunology, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ⁵Bone and Joint Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain
Background/Purpose: The term interstitial pneumonia with autoimmune features (IPAF) has recently been proposed to identify those patients with ILD and clinical and/or serological autoimmune manifestations…
Abstract Number: 1276 • 2017 ACR/ARHP Annual Meeting
Nail Fold Capillary Changes Are Associated with Pulmonary, but Not with Cardiac Involvement in Juvenile Dermatomyositis
Zoltán Barth^1,2,3, Thomas Schwartz^2,4, Berit Flatø^5,6, Akos Koller^7,8, May Brit Samersaw-Lund⁹, Ivar Sjaastad^10,11 and Helga Sanner⁶, ¹Bjorknes College, Oslo, Norway, ²Oslo University Hospital and University of Oslo, Institute for Experimental Medical Research, Oslo, Norway, ³Medical School, University of Pecs, Institute for Translational Medicine, Pecs, Hungary, ⁴Institute for Experimental Medical Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway, ⁵Institute for Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway, ⁶Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Oslo, Norway, ⁷University of Physical Education, Institute of Natural Sciences, Budapest, Hungary, ⁸Medical School, University of Pecs, Department of Neurosurgery, Pecs, Hungary, ⁹Oslo University Hospital, Rikshospitalet, Department of Respiratory Medicine, Oslo, Norway, ¹⁰Department of Cardiology, Oslo University Hospital, Oslo, Norway, Oslo, Norway, ¹¹Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway, Oslo, Norway
Background/Purpose: Juvenile dermatomyositis (JDM) is a rare autoimmune disease of unknown origin, characterised primarily by cutaneous rashes and symmetrical weakness of the proximal skeletal muscles.…
Abstract Number: 1389 • 2016 ACR/ARHP Annual Meeting
Alterations in Nailfold Capillaroscopy in Childhood-Onset Systemic Lupus Erythematosus: The Role of Disease Activity in a Prospective Study
Nadia E Aikawa¹, Luiz Sousa², Mariana O Perez³, Ana Paula Luppino-Assad⁴, Rosa M R Pereira⁵ and Maria Teresa Caleiro², ¹Pediatric Rheumatology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²Rheumatology Division, University of São Paulo, São Paulo, Brazil, ³Rheumatology Divison, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁴Division of Rheumatology, University of São Paulo, sao paulo, Brazil, ⁵Rheumatology, University of São Paulo, São Paulo, Brazil
Background/Purpose: The association between disease activity and nailfold capillaroscopy (NC) alterations has been described in systemic lupus erythematosus (SLE). However, data on longitudinal assessment of…
Abstract Number: 1874 • 2016 ACR/ARHP Annual Meeting
Low Rate of Progression in Cases of Isolated Raynaud’s Phenomenon Screened By Nailfold Videocapillaroscopy and Antinuclear Antibody Status Supports Negative Predictive Value of These Tests
Louise Parker¹, Kevin Howell², Voon H. Ong³ and Christopher P.Denton⁴, ¹Centre for Rheumatology and Connective Diseases, UCL Medical School and Royal Free Hosp, London, United Kingdom, ²Institute of Immunity and Transplantation, University College London, Royal Free Campus, London, United Kingdom, ³Rheumatology, UCL Division of Medicine, London, United Kingdom, ⁴Centre of Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom
Background/Purpose: Raynaud’s phenomenon is common but can progress to definite connective tissue disease. We have observed long term follow up of an unselected consecutive…
Abstract Number: 1885 • 2016 ACR/ARHP Annual Meeting
Can Nailfold Videocapillaroscopy Images be Interpreted Reliably By Different Observers? Results of an Inter-Reader and Intra-Reader Exercise Among Rheumatologists with Different Experience in This Field
Tatiana Sofia Rodriguez-Reyna¹, Chiara Bertolazzi², Angelica Vargas Guerrero³, Marwin Gutierrez⁴, Gabriela Hernandez-Molina⁵, Marcelo Audisio⁶, Susana Roverano⁷, Margarita González de Urizar⁸, José Francisco Díaz Coto⁹, Blanca Herrera Velasco¹⁰, Mijahil Cornejo Ortega¹¹, Ana María Sapag Durán¹², Janeth Villegas Guzmán¹³, Luìs Fernando Medina Quintero¹⁴, Mirtha Sabelli¹⁵, Carlos Velasquez¹⁶, Sandy Sapag Durán¹⁷, Oscar Sedano¹⁸, Martín Zapata Zúñiga¹⁹, Maria Fonseca²⁰, Maurizio Cutolo²¹ and PANLAR Capillaroscopy Group, ¹Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ²Rheumatology, Instituto Nacional de Rehabilitación, Mexico City, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ⁴Instituto Nacional de Rehabilitación, Mexico, Mexico, ⁵Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico City, Mexico, ⁶Servicio de Reumatología del Hospital Nacional de Clínicas, Córdoba, Argentina, ⁷Rheumatology, Hospital Jose Maria Cullen, Santa Fe, Argentina, ⁸Rheumatology, Hospital San Ramón, Ciudad del Este, Paraguay, ⁹Rheumatology, Hospital Clínica Bíblica, San José, Costa Rica, ¹⁰Rheumatology, Universidad de San Fancisco Xavier de Chuquisaca, Sucre, Bolivia (Plurinational State of), ¹¹Rheumatology, Hospital Nacional Arzobispo Loayza, Lima, Peru, ¹²Rheumatology, Hospital Universitario Japonés, Santa Cruz, Bolivia (Plurinational State of), ¹³Rheumatology, Hospital Nacional Dos de Mayo, Lima, Peru, ¹⁴Internal Medicine, Universidad del Valle, Cali, Colombia, ¹⁵Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, ¹⁶Clínica Universitaria Bolivariana, Universidad Pontificia Bolivariana, Medellín, Colombia, ¹⁷Reumatología, Instituto de Investigación en Reumatología Sapag & Sapag, Santa Cruz de la Sierra, Bolivia (Plurinational State of), ¹⁸Rheumatology, Hospital Marino Molina Scippa ESSALUD, Lima, Peru, ¹⁹Rheumatology, Hospitl General Jerez, Jerez, Mexico, ²⁰Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ²¹Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genova, Italy
Background/Purpose: Nailfold videocapillaroscopy (VCP) has become an established method to assess the microcirculation in patients with Raynaud’s phenomenon and connective tissue diseases. The 2013 Systemic…
Abstract Number: 2913 • 2016 ACR/ARHP Annual Meeting
Four Year Effects of Combined Bosentan and Iloprost Treatment on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion and Clinical Status, in Systemic Sclerosis Patients
Amelia Chiara Trombetta¹, Carmen Pizzorni², Barbara Ruaro³, Sabrina Paolino³, Alberto Sulli², Vanessa Smith⁴ and Maurizio Cutolo³, ¹Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genova, Italy, ²Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genova, Italy, ³Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genoa, Italy, ⁴Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium
Background/Purpose: In systemic sclerosis (SSc), microvascular damage progresses from capillary dilation to capillary loss and reactive angiogenesis, as detectable by nailfold videocapillaroscopy (NVC) [1]. The…
Abstract Number: 193 • 2015 ACR/ARHP Annual Meeting
Going Back to Basics – Redefining the Normal Pattern in Nailfold Capillaroscopy in a Large Healthy Population: Results of the German “Rheuma-Truck” Cohort
Moritz Schröder, Department of Rheumatology and Hiller Research Institute, Heinrich-Heine University, Duesseldorf, Germany
Background/Purpose: Capillaroscopy is as a useful diagnostic tool in various connective tissue diseases characterized by microangiopathy and vasculitis. Different pathological patterns especially for systemic sclerosis…
Abstract Number: 273 • 2015 ACR/ARHP Annual Meeting
Progression Predictive Factors in Patients with Undifferentiated Connective Tissue Disease: A Cohort Study
Maria Garcia-Gonzalez, Esmeralda Delgado-Frias, Sagrario Bustabad, Ivan Ferraz-Amaro and Beatriz Rodriguez-Lozano, Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
Background/Purpose: In recent years there has been a growing interest in establishing the concept of Undifferentiated CTD (UCTD) and defining its clinical evolution. Remarkable are…
Abstract Number: 1925 • 2015 ACR/ARHP Annual Meeting
Interleukin-35 Is Upregulated in Systemic Sclerosis and Its Serum Levels Are Increased in Early Disease
Michal Tomcík¹, Pawel Zerr², Katrin Palumbo-Zerr², Hana Storkanova¹, Hana Hulejova³, Maja Spiritovic⁴, Ondrej Kodet⁵, Jiri Stork⁵, Radim Becvar¹, Jiri Vencovsky¹, Karel Pavelka⁶, Maria Filkova⁷, Jorg HW Distler² and Ladislav Senolt⁸, ¹Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, ²Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ³Institute of Rheumatology and Department of Rheumatology, Prague, Czech Republic, ⁴Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, ⁵Department of Dermatology and Venereology, First Faculty of Medicine, Charles University, Prague, Czech Republic, ⁶Charles University, Prague, Czech Republic, ⁷Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, ⁸Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic
Background/Purpose: Interleukin-35 (IL-35) is the most recent addition to the IL-12 family, which also comprises IL-12, IL-23 and IL-27. IL-35 consists of two chains, p35/IL-12a…
Abstract Number: 2255 • 2015 ACR/ARHP Annual Meeting
Capillaroscopic Patterns in a Healthy Population
Génessis Maldonado¹, Christian Ferro², Carlos Ríos³ and Karla Ríos¹, ¹Universidad Espíritu Santo, Guayaquil, Ecuador, ²Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador, ³Centro de Reumatología y Rehabilitación CERER, Guayaquil, Ecuador
Background/Purpose: Capillaroscopy is a noninvasive and safe method that allows visualization of the capillaries in the finger nailfold, it is useful in the evaluation of…
Abstract Number: 2971 • 2015 ACR/ARHP Annual Meeting
Raynaud Phenomenon Subjects with Abnormal Capillary Dilations Show a Risk Threshold Diameter Value for the Transition to the Capillaroscopic Early� Scleroderma Pattern: A Case Control Study
Maurizio Cutolo¹, Carmen Pizzorni², Marianna Meroni², Vanessa Smith³, Sabrina Paolino², Barbara Ruaro², Alberto Sulli², Bruno Seriolo² and Amelia Chiara Trombetta², ¹Department of Internal Medicine, University of Genova, Genova, Italy, Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy, ²Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy, ³Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium
Background/Purpose: Nailfold Video Capillaroscopy (NVC) is a reliable method to qualitatively differentiate Primary (PRP) from Secondary Raynaud Phenomenon (SRP) through diagnosis of the “early scleroderma…
Abstract Number: 2710 • 2014 ACR/ARHP Annual Meeting
The New ACR-EULAR 2013 Systemic Sclerosis Classification Criteria Show Good Performance in a Capillaroscopy Clinic
Patricia E. Carreira¹, M Jesus Garcia de Yebenes², Beatriz E. Joven^1,3, Estibaliz Loza² and Loreto Carmona², ¹Rheumatology Department. Hospital Universitario 12 de Octubre, Madrid, Spain, ²Instituto de Salud Musculoesqueletica, Madrid, Spain, ³Rheumatology, HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Madrid, Spain
Background/Purpose: To analyze the validity of the new 2013 ACR-EULAR Systemic Sclerosis (SSc) classification criteria versus SSc clinical diagnosis in patients from a capillaroscopy clinic…
Abstract Number: 1926 • 2014 ACR/ARHP Annual Meeting
Nailfold Videocapillaroscopy Patterns Associated with Calcinosis and Acro-Osteolysis in Systemic Sclerosis
Jerome Avouac¹, Laetitia Morardet², Maya Sammour³, Andre Kahan², Antoine Feydy³ and Yannick Allanore¹, ¹Paris Descartes University, Rheumatology A Department and INSERM U1016, Cochin Hospital, Paris, France, ²Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France, ³Paris Descartes University, Radiology B department, Cochin Hospital, Paris, France
Background/Purpose: Calcinosis and acro-osteolysis are frequent in systemic sclerosis (SSc). They may be related to digital vasculopathy, which can be assessed by nailfold videocapillaroscopy (NVC).…
Abstract Number: 2583 • 2013 ACR/ARHP Annual Meeting
Long-Term Treatment With Endothelin Receptor Antagonist Increases Peripheral Blood Perfusion In Systemic Sclerosis Patients
Maurizio Cutolo¹, Barbara Ruaro², Elena Bernero², Francesca Ravera³, Giuseppe Zampogna³, Elisa Alessandri², Vanessa Smith⁴ and Alberto Sulli³, ¹Internal medicine, Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, ²Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, ³Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, ⁴Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Background/Purpose: Systemic sclerosis (SSc) is characterized by progressive impairment of the microvascular system and decrease of peripheral blood perfusion (PBP) (1-3). The vasoactive peptide endothelin-1…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.